N-(3-nitrophenyl)-3-oxobutanamide | CAS:25233-49-2

We serve N-(3-nitrophenyl)-3-oxobutanamide CAS:25233-49-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
N-(3-nitrophenyl)-3-oxobutanamide

Chemical Name: N-(3-nitrophenyl)-3-oxobutanamide
CAS.NO:25233-49-2
Synonyms:Acetoacet-m-nitroanilide(AAMNA);N-(3-Nitro-phenyl)-3-oxo-butyramide;acetoacetic acid-(3-nitro-anilide);3-Nitro-acetoacetanilid;3'-nitroacetoacetanilide
Molecular Formula:C10H10N2O4
Molecular Weight:222.19700
 
Physical and Chemical Properties:
Density:1.35g/cm3
Boiling point:439.7ºC at 760 mmHg
Melting point:/
Flash point:/
Index of Refraction:1.601
 
Specification:
Appearance:Bright yellow crystalline powder
Purity:≥99.0%
 
Packing: 25kg drum
Storage:Ware house ventilation and low temperature drying
Application: Mainly used in synthetic pigments, dye couplings.



Contact us for information like N-(3-nitrophenyl)-3-oxobutanamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3′-nitroacetoacetanilide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Nitro-acetoacetanilid Use and application,acetoacetic acid-(3-nitro-anilide) technical grade,usp/ep/jp grade.


Related News: Fears over the continuing spread of coronavirus have also fueled resentment and discrimination. Some have become outcasts in their own country, shunned by hotels, neighbors and — in some areas — placed under controversial quarantine measures.2-thioladenosine manufacturer Ten domestic API leading enterprises of CSPC, Puluo Pharmaceutical, Huahai Pharmaceutical, Chuang Nuo Pharmaceutical, Federal Pharmaceuticals, Zhejiang Pharmaceutical, Yifan Pharmaceutical, Jiangxi Tianxin, Zhejiang Chemical Industry, and Xinhua Pharmaceutical rank among China’s API exporters The top ten in the list.Silicic acid, methyl ester supplier Rigosertib, in its intravenous formulation, is currently in Phase 3 clinical development for the treatment of higher-risk MDS.Bis(2-oxo-3-oxazolidinyl)phosphinic chloride vendor The slowdown of pesticide intermediates has dragged down the growth of industrial business. In the future, the pharmaceutical intermediate business will be the focus of the company’s development.We purchase the raw materials from raw material or chemical product manufacturers both in Japan and internationally.